Need for a cooperative study: Pulmonary Langerhans cell histiocytosis and its management in adults

Medical and Pediatric Oncology

Volumn 39, Issue 1, 2002, Pages 35-39

  McClain, Kenneth L ^a,e   Gonzalez, Jorge Mario ^a   Jonkers, Rene ^b   De Juli, Emanuela ^d   Egeler, Maarten ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e TEXAS CHILDREN S CANCER CENTER   (United States)

Author keywords

Langerhans cell histiocytosis (histiocytosis X); Lung

Indexed keywords

ANTINEOPLASTIC AGENT; STEROID;

ADULT; ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; HISTIOCYTOSIS X; HUMAN; LUNG DISEASE; LUNG INSUFFICIENCY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SMOKING;

BONE DISEASES; DIABETES INSIPIDUS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LUNG; MULTICENTER STUDIES; PROGNOSIS; REMISSION, SPONTANEOUS; RISK FACTORS; SKIN DISEASES;

EID: 0036102296     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10064     Document Type: Article

References (34)

1. Polyuria and tuberculosis
2. A leukamische retikulose (ein Beitrag zu den proliferativen erkrankungen des reticuloendothelialapparates
3. Skeletal lipoid granulomatosis (Hand-Schüller-Chrisitan's disease)
4. Histiocytosis X. Integration of eosinophilic granuloma of bone. "Letterer-Siwe Disease", and "Schüller-Christian Disease" as related manifestations of a single nosologic entity
5. Histiocytosis X. Histogenetic arguments for a Langerhans cell origin
6. Uber die nerven der menslichen Haut
7. Pulmonary histiocytosis X
8. An electron microscope study of basal melanocytes and high level clear cells (Langerhans cells) in vitiligo
9. Histiocytosis X (Langerhans'Cell Histiocytosis)
10. Histiocytosis syndromes in children
11. Clinical aspects of Langerhans cell histiocytosis
12. Langerhans cell histiocytosis: Lack of a viral etiology
13. Differential in situ cytokine profiles of Langerhans-like cells and T-cells in Langerhans cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment
14. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: Importance of the cytokine microenvironment
15. Pathogenesis of adult pulmonary Langerhans-cell histiocytosis
16. Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells
17. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytois are mature dendritic cells: Importance of the cytokine microenvironment
18. Pulmonary Langerhans' cell histiocytosis: Molecular analysis of clonality
19. Langerhans cell histiocytosis: Expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation
20. Lung involvement in Langerhans' cells histiocytosis: Prevalence, clinical features, and outcome
21. Langerhans cell histiocytosis: Diagnosis, natural history, management, and outcome
22. Eosinophilic granuloma of lung. Clinical aspects of primary pulmonary histiocytosis in the adult
23. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X
24. Pulmonary Langerhans cell granulomatosis (histiocytosis X): A clinicopathologic study of 48 cases
25. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X)
26. Pulmonary and mediastinal lesions in children with Langerhans cell histiocytosis
27. Primary pulmonary histiocytoses X: A case report and literature review of pediatric cases
28. Pulmonary abnormalities at long-term follow-up of patients with Langerhans cell histiocytosis
29. Pulmonary histiocytosis X: Pulmonary function and exercise pathophysiology
30. Is high-resolution comuted tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis?
31. Pulmonary Langerhans' cell histiocytosis
32. Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis
33. Treatment strategy for disseminated Langerhans cell histiocytosis
34. Controversies and new approaches to treatment of Langerhans cell histiocytosis